FDA.reportPublic FDA data

Chlamydia trachomatis nucleic acid IVD, control

Definition
A material which is used to verify the performance of an assay intended to be used for the qualitative and/or quantitative detection of nucleic acid from Chlamydia trachomatis bacteria in a clinical specimen.
GUDID devices
8
Last updated
2021-06-21 07:29:38

Representative GUDID Devices#

Primary DI, Brand, Company table
Primary DIBrandCompanyModelPublished
01220000260269NATtrol™ZEPTOMETRIX CORPORATIONNATtrol™ Chlamydia trachomatis (CT) Positive Cont2021-06-11
01220000260283NATtrol™ZEPTOMETRIX CORPORATIONNATtrol™ Chlamydia trachomatis/Neisseria gonorrhoe2021-06-11
01220000260023NATtrol™ZEPTOMETRIX CORPORATIONNATtrol™ Chlamydia trachomatis Positive Controls 2020-10-15
01220000260047NATtrol™ZEPTOMETRIX CORPORATIONNATtrol™ Chlamydia trachomatis/Neisseria gonorrhoe2020-10-15
10845357042092Helix Elite™ Molecular Standards: Inactivated StandardMICROBIOLOGICS INC.HE0035N2020-04-30
00382904404512BD ProbeTec™ ET Control SetBECTON, DICKINSON AND COMPANY4404512016-07-07
00382904411251Control Set for the BD ProbeTec™ (CT/GC)BECTON, DICKINSON AND COMPANY4411252016-07-08
00382904419257Control Set for the BD ProbeTec™ CT/GC/TV Qx Amplified DNA AssaysBECTON, DICKINSON AND COMPANY4419252016-07-07